Sunwin ( SUWN ) explodiert !
Seite 13 von 102 Neuester Beitrag: 25.04.21 03:17 | ||||
Eröffnet am: | 24.01.06 12:38 | von: gameznman | Anzahl Beiträge: | 3.526 |
Neuester Beitrag: | 25.04.21 03:17 | von: Brigitteojnfa | Leser gesamt: | 558.063 |
Forum: | Hot-Stocks | Leser heute: | 285 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 10 | 11 | 12 | | 14 | 15 | 16 | ... 102 > |
0.6050$ 0.5783$ 0.6033$ 0.6283$
Wiederstand bei 0,53 Euro
Unterstütztung 0,48
Sunwin International Neutraceuticals Forms a US Subsidiary to Distribute Stevia in the US
FORT LAUDERDALE, FL and QUFU, CHINA -- (MARKET WIRE) -- 02/15/06 -- Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN), an industry leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, has formed a wholly owned subsidiary, Sunwin Stevia International Corp, in order to aggressively market its Stevia throughout the US.
Stevia, a 100% natural sweetener, is extracted from the leaves of the Stevia rebaudiana plant, as a food additive which is used in various products such as beverages, foods, confections, and medicinal products in China and Japan. Forms of Stevia are approximately 300 times sweeter than general sucrose, with only 1/300th of the calories. Stevia is often referred to as the third generation of natural low calorie sweetener.
Mr. Laiwang Zhang, President and Chairman of Sunwin International, commented, "We are very excited about the potential that the US Stevia distribution can bring to the company. We have contracted marketing professionals to guide our operations in the US. We will start our operations in Florida and California. We believe there are tremendous needs for our Stevia in the US marketplace, as there are over 20.8 million diabetic patients and an additional 41 million Americans with pre-diabetes in the US."
Mr. Zhang further stated, "Obesity is at epidemic proportions, with the largest increase in young children. Stevia use by diabetics as well as health conscious individuals in the US has been growing substantially over the last 15 years. More and more parents are becoming aware of shopping for food products and supplements with reduced sugar levels. The average Stevia user spends $80 on product per year."
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, low-calorie natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important, innovative, high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit http://www.sunwin.biz
Safe Harbor Statement
Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
Contact:
Market Solutions, LLC
Tel: (561) 487-3674
Fax: (561) 237-2925
Email: info@sunwin.biz
Media/Analyst Contact:
Alan Stone & Company LLC
Alan Stone
212-521-4102
astone@alanstone.com
Quelle
in 12 monaten, spricht keiner mehr von 0,....
sondern von 3,00.- bis 4,50.-€
Detailed Quote Snapshot 02/15/2006 02:38 PM
Last:
0.74 suwn - SUNWIN INTL NEUTRACEUTICAL I
Change:
+0.14 % Change:
+23.14% High:
0.75 Low:
0.64 Volume:
2,020,345
Price Data Table
Open 0.64
Previous Close 0.74
Exchange of Last Sale OTCBB
Time of Last Sale 14:35:02
Tick Up
Bid 0.744
Ask
Size Bid/Ask 25x26
Symbol Type Equity
Fundamental Data Table
52 Week High 0.97
52 Week Low 0.02
EPS 0.05
P/E Ratio 12.10
Shares Outstanding 40,000,000
Market Cap 29,558,000
Beta 61.295
Dividend Frequency
Ex-Dividend Date
Dividend Amount
Yield 0.00
Primary Exchange OTCBB
Wie ich es immer gepostet habe.
Freu mich für alle die dabei sind!
Tja, morgen wird die erst mal kräftig nach oben schießen und das Plus aus USA nachvollziehen - und dann? Bei einem Kursziel von 1,50 ist natürlich theoretisch egal, wann man einsteigt...
Die Aktie ist weiter ein Kauf, nicht nur wegen der guten News sondern auch die bedrohliche situation mit dem h5n1 Virus gibt einen zusätzlichen schub.
Die Aktie Sunwin, wird sich bis Ende der woche also übermorgen über 1,00.-$ wenn nicht sogar 1,20.-$ etablieren. Dann muss man abwarten wie sich die medien progaganda übers Wochenende mit der Vogelgrippe weiter entwickelt.
Unteranderem, kann man davon ausgehen, dass weitere positiven News kommen und dann marschiert die Aktie weiter nach Norden.
Mein Kursziel auf 12 Monate: 3,00.-€ bis 4,50.-€
Der wichtigste Schritt war die heute vermeldete News, Sunwin wird wahnsinns Umsätze und Gewinne vermelden können in den folgenden Quartalen.
Weitere expansionen sehe ich ebenfalls in naher Zukunft aus strategischer sicht für sehr wahrscheinlich.
Doch nicht desto trotz, kann eine Übernahme die ganze Story noch vergolden ;-)
Mein Fazit, im Depot lassen und bei Gewinnmitnahmen/konsolidierungen nachkaufen. Solange wird unter 1,50.-€ sind ist die Aktie ein 100% kauf.
Bis dann
sergev
Auf der Seite von Sunwin http://www.sunwin.biz erfährt man, dass 2006 300 Tonnen des Süßstoffes produziert werden sollen. Das sind 300.000 kg Süßstoff, bei der Süßkraft des 300fachen von Zucker ersetzt der Stoff 90.000.000 kg Zucker. Der Zuckerpreis am Weltmarkt lag im Sept. 2005 bei etwa 22 Cent pro kg (http://www.faz.net/s/...986AF94E72D8C58FB~ATpl~Ecommon~Scontent.html) und ist durch die Transportkosten an den Ölpreis gekoppelt. 90.000 Tonnen Zucker haben also einen Marktpreis von knapp 20 Mio. Euro. Der Zuckerpreis ist im letzten Jahr um 26% gestiegen. China hat 2005 den Import von Zucker um etwa 57% gesteigert.
Weniger glaubwürdig halte ich dagegen die Behauptung, Sunwin habe ein Kraut gegen die Vogelgrippe gefunden. Davon konnte ich auch auf der Sunwin Seite nichts finden. Hat jemand dazu eine Quellenangabe?
Ich habe Sunwin jedenfalls übergewichtet, weil die Firma in einem Zukunftsmarkt tätig und von der Chinesischen Regierung anerkannt und prämiert ist.
Gruß
wolle65
Local Government Designates Veterinary Disinfectants Produced by Sunwin International Neutraceuticals as a Primary Response to Combat the Avian Flu
FORT LAUDERDALE, FL and QUFU, CHINA -- (MARKET WIRE) -- 12/07/05 -- Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN), an industry leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, announces the Jining City Government has designated Sunwin's veterinary disinfectants as a primary response to combat the avian flu virus. Jining City, situated in the southwestern region of the Shandong Province, administers 12 districts, counties and cities including Qufu where Sunwin is headquartered. The Jining City government services a population of 7.56 million within 4,200 square miles. Sunwin is the only provider of veterinary disinfectants in Jining City.
Sunwin has developed a series of veterinary disinfectants employing traditional Chinese herbal medicine devised to combat the avian flu virus. The new line of disinfectants has been proven effective in inhibiting the spread of the H5N1 and H9N2 strands of the avian flu. The new series of veterinary disinfectants meets national sanitary standards established by the central government. Recently, Sunwin announced that the department of Livestock and Farming for Shandong Province Government has submitted a fast-track application to the Livestock Farming Bureau of China Ministry of Agriculture on behalf of Sunwin International Neutraceuticals, Inc.
Laiwang Zhang, President and Chairman of Sunwin International Neutraceuticals, Inc., stated, "The central government is mobilizing to prepare for a potential avian flu pandemic. Following the wave of reported cases of avian flu in China, we hope to witness strong demand for our products. Sunwin is committed to providing a solution to combat the avian flu."
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, low-calorie natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit http://www.sunwin.biz
Safe Harbor Statement
Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
Contact:
Christina Hanneman
Tel: 303-220-8476
Fax: 303-773-6492
Email: chrishanneman@mho.com
Sunwin International Neutraceuticals, Inc.
http://www.wallstreetresearch.org/reports/suwn.htm
The Company sells stevioside on a wholesale basis to domestic food manufacturers and large foreign trade companies, which export the products to Japan, South Korea, as well as other countries in Southeast Asia and to a lesser extent globally. Stevioside is sanctioned by the Ministry of Health of China for use as a food additive and listed in the Sanitation Standard of Food Additives (GB2760). Similarly, stevia products are allowed to be sold as a food ingredient in much of Asia, including Japan, South Korea, Taiwan, Malaysia and Indonesia, parts of South America, such as Brazil and Paraguay, some Eastern European countries and Switzerland, as well as Israel and South Africa. However, some major global markets, including the U.S., the European Union (EU) and Australia, where stevioside is permitted only as a dietary supplement, remain largely inaccessible to producers of stevia-based sweeteners. In the U.S., without a GRAS (Generally Recognized As Safe) designation from the Federal Drug Administration (FDA), stevia use is limited to the confines of the Dietary Supplement and Health Education Act. As such, stevioside products are labeled, marketed and sold as dietary supplements, mostly in form of teas and shakes, but sometimes also as stand-alone extracts, which can effectively serve as sweeteners. The U.S. retail market for stevia products, which are primarily distributed through major health food stores like GNC and Whole Foods Market, although growing quickly, is currently estimated at only $20 million. The Company recently entered into an exclusive distribution agreement for its sweetener extract with United States Distribution Corp., which has strong relationships with 55,000 retail outlets across the U.S., including warehouses, mass retailers, grocery stores, pharmacies, restaurants, hotels, casinos, convention centers, stadium concessions, gas stations, convenience stores, and natural food chain stores. With superior taste than synthetic sweeteners and no known side effects, stevia products should eventually successfully compete within the $25 billion sweetener market in the U.S., as well as other industrialized markets currently dominated by aspartame-based products such as NutraSweet® or Equal®.
Nachtschwärmer IborCity
ist dies die raktion auf gestern in US, oder legt Deutschland heute wieder etwas vor, was dann in US weitergeht
Kursziel: 12 monate 3,00-4,00.-
Also die angesprochene Rallye, wird noch 8 bis 10 monate andauern ;-)